Abstract

Recent research has revealed a role for Ambra1, an autophagy-related gene-related (ATG) protein, in the autophagic pro-survival response, and Ambra1 has been shown to regulate Beclin1 and Beclin1-dependent autophagy in embryonic stem cells. However, whether Ambra1 plays an important role in the autophagy pathway in colorectal cancer cells is unknown. In this study, we hypothesized that Ambra1 is an important regulator of autophagy and apoptosis in CRC cell lines. To test this hypothesis, we confirmed autophagic activity in serum-starved SW620 CRC cells by assessing endogenous microtubule-associated protein 1 light chain 3 (LC3) localization, the presence of autophagosomes (transmission electron microscopy) and LC3 protein levels (Western blotting). Ambra1 expression was detected by Western blot in SW620 cells treated with staurosporine or etoposide. Calpain and caspase inhibitors were employed to verify whether calpains and caspases were responsible for Ambra1 cleavage. To examine the role of Ambra1 in apoptosis, Ambra1 knockdown cells were treated with staurosporine and etoposide. Cell apoptosis and viability were measured by annexin-V and PI staining and MTT assays. We determined that serum deprivation-induced autophagy was associated with Ambra1 upregulation in colorectal cancer cell lines. Ambra1 expression decreased during staurosporine- or etoposide-induced apoptosis. Calpains and caspases may be responsible for Ambra1 degradation. When Ambra1 expression was reduced by siRNA, SW620 cells were more sensitive to staurosporine- or etoposide-induced apoptosis. In addition, starvation-induced autophagy decreased. Finally, Co-immunoprecipitation of Ambra1 and Beclin1 demonstrated that Ambra1 and Beclin1 interact in serum-starved or rapamycin-treated SW620 cells, suggesting that Ambra1 regulates autophagy in CRC cells by interacting with Beclin1. In conclusion, Ambra1 is a crucial regulator of autophagy and apoptosis in CRC cells that maintains the balance between autophagy and apoptosis.

Highlights

  • Colorectal cancer (CRC) is one of the most common digestive cancers worldwide

  • We found that Ambra1 interacts with Beclin1 to function as a pro-survival switch that inhibits apoptosis and induces autophagy, thereby preventing CRC cell death in response to apoptotic agents

  • We examined the role of Ambra1 in autophagy and apoptosis in SW620 colorectal cancer cells

Read more

Summary

Introduction

Colorectal cancer (CRC) is one of the most common digestive cancers worldwide. Recently, combination therapy has improved the prognosis for CRC patients. Chemotherapy resistance is a serious issue that is associated with poor prognosis and treatment problems [2], and autophagy may contribute to chemoresistance in CRC cells [3]. Autophagy is a highly conserved self-digestion process in eukaryotic cells that involves the degradation of old organelles and proteins to obtain energy. Ambra is a newly discovered ATG gene, and the Ambra protein is a crucial regulator of autophagy. The function of Ambra in autophagy and apoptosis has been explored in vitro in embryonic stem cells and human fibroblast 2FTGH (2F) cells [13], but the role of Ambra in CRC cell lines has not been reported in the literature, and the role of this ATG protein in the autophagy and apoptosis pathways in CRC cell lines is unknown

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call